查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1541555

生物材料市場報告（按類型（天然生物材料、金屬生物材料、陶瓷生物材料、聚合生物材料）、應用（神經病學、心臟病學、骨科、傷口護理、牙科、整形外科等）和地區 2024-2032

Biomaterials Market Report by Type (Natural Biomaterial, Metallic Biomaterial, Ceramic Biomaterial, Polymeric Biomaterial), Application (Neurology, Cardiology, Orthopedics, Wound Care, Dental, Plastic Surgery, and Others), and Region 2024-2032
出版日期: | 出版商: IMARC | 英文 140 Pages | 商品交期: 2-3個工作天內

價格

IMARC Group年全球生物材料市場規模達1,146億美元。醫療保健產業的不斷進步，以及心血管疾病盛行率的上升，主要推動了市場的發展。

生物材料市場分析：

主要市場促進因素：患有肌肉骨骼疾病的人數不斷增加是刺激市場的主要促進因素之一。此外，這些材料擴大用於可溶解的縫合線和敷料、U形釘和傷口閉合夾子中，也是另一個重要的生長誘導因素。

主要市場趨勢：聚合物合成、蛋白質和胜肽工程、分子自組裝和微加工技術的多項進步是支撐市場的新興趨勢。

地理趨勢：由於經常需要醫療干預的老年人口不斷增加，北美在整個市場上表現出明顯的主導地位。此外，研究機構數量的增加和強大的醫療基礎設施正在推動區域市場的成長。

競爭格局：根據生物材料市場概況，一些知名公司包括巴斯夫SE、柏克萊先進生物材料、Carpenter Technology Corporation、Collagen Matrix Inc.、CoorsTek Inc.、Corbion NV、Dentsply Sirona、Evonik Industries AG、Johnson & Johnson、 Koninklijke DSM NV、Medtronic plc、Stryker Corporation、Victrex plc 和Zimmer Biomet 等。

挑戰與機會：嚴格的監管框架和廣泛的臨床前測試正在阻礙市場。然而，在臨床使用前引入更具預測性的體內和體外模型來評估生物相容性預計將在預測期內擴大市場。

生物材料市場趨勢：

3D列印技術的發展

包括 3D 列印技術在內的新穎創新的引入正在改善醫療植入物和設備的設計和製造方式。此外，它們還可以生產針對患者的複雜形狀，這是傳統方法難以或不可能實現的。因此，這些技術在牙科、骨科、義肢等解剖精準度至關重要的領域中得到了廣泛的應用。反過來，這也是生物材料市場近期利潤豐厚的機會之一。例如，2024年2月，納瓦蒂馬克斯超級專科醫院在孟買啟用了醫療3D列印實驗室，以方便高精度手術。這項開創性的設施與腫瘤學緊密結合，提供最先進的精密手術，這些手術需要在重建骨科、腫瘤學和專業牙科手術中準確、仔細地進行。此外，3D 列印技術在生物材料中的廣泛整合，用於創建根據患者個體解剖結構客製化的複雜醫療設備和植入物，進一步在全球範圍內獲得廣泛關注。例如，2023年10月發表的一項研究，協助卑爾根Haukeland大學醫院的職業治療師利用3D列印和掃描技術開發個人化手部矯形器，可以減輕疼痛、最大限度地減少病情惡化、提高患者的依從性等。例如，2023 年 10 月，贏創推出了適用於眾多醫療應用的植入級長絲和碳纖維增強 PEEK。此外，這些技術有助於治療慢性疾病，預計將推動未來幾年的整體生物材料市場前景。例如，2023年7月，透過與韓國生物科學與生物技術研究所、韓國機械與材料研究所以及科學資訊通訊部下屬研究所聯合研究，推出了全球首個3D生物列印技術，增強了自然殺傷（ NK）免疫細胞的功能。

組織工程的創新

組織工程在生物材料研究中扮演重要角色。開發生物替代品以維持、恢復或改善組織功能越來越受歡迎。例如，2023年6月，OrganaBio宣布推出NeoPAC胎盤和臍帶組織，專門用於加速再生醫學和細胞治療的進展。此外，透過提供僅供研究使用 (RUO) 和臨床級組織，OrganaBio 鼓勵研究人員挖掘出生組織的潛力，從而開發創新療法來解決多種醫療狀況。除此之外，對新型支架的需求不斷成長，這些支架是經過工程設計以引起所需的細胞相互作用以促進新組織形成的材料，這也推動了市場的發展。例如，2023年6月，組織工程領先創新者之一的3DBioFibR發布了兩款新的膠原纖維產品，即CollaFibR 3D和μCollaFibR支架。這些變體為組織培養和組織工程應用提供了顯著的好處。此外，各個組織增加對研發活動和研究設施的投資，以實現結構和功能更精確的組織工程，這也為生物材料市場收入做出了貢獻。例如，2023年1月，國家生物醫學影像與生物工程研究所（NIBIB）成立了生物醫學工程技術加速中心（BETA中心），這是一個新的校內研究項目，旨在加速尖端技術的驗證、開發和傳播。該中心重點關注生物感測、工程與合成生物學、生物醫學成像、奈米材料與生物材料等多個領域。

在傷口敷料中的不斷成長的應用

先進傷口敷料中擴大採用生物材料，因為它們有助於改善多種類型傷口（包括急性和慢性損傷）的癒合過程和結果，是一個重要的生長誘導因素。除此之外，主要參與者正在開發用於傷口護理的永續材料。例如，2024年3月，科技部科學技術高等研究院（IASST）的科學家團隊推出了一種由香蕉纖維製成的環保傷口敷料材料。此外，用於製造這種創新敷料材料的所有材料均來自當地且天然，使得製造過程具有成本效益、簡單且無毒。除此之外，人們對基於生物材料的傷口敷料的日益青睞正在提高生物材料的市場價格。它們可以由各種材料製成，包括泡沫、水凝膠、薄膜等，這些材料通常充滿抗菌劑等生物活性物質，以減少感染並促進組織再生。例如，2022 年 5 月，瑞典醫療器材新創公司 Amferia AB 獲得美國專利商標局 (USPTO) 授予的基於兩親性抗菌水凝膠的抗菌材料的基礎專利。與此一致的是，根據發表在《生物材料進展雜誌》上的研究結果，貝爾法斯特女王大學的一組研究人員於2023 年6 月設計了一種3D 列印繃帶，也稱為支架，它提供了一種創新的治療方法來治癒糖尿病足潰瘍（DFU）。

全球生物材料市場細分：

IMARC Group提供了市場各個細分市場的主要趨勢的分析，以及 2024-2032 年全球、區域和國家層面的生物材料市場預測。我們的報告根據類型和應用程式對市場進行了分類。

按類型分類：

天然生物材料

金屬生物材料

陶瓷生物材料

高分子生物材料

目前，金屬生物材料佔據最大的市場佔有率

該報告根據類型提供了詳細的市場細分和分析。這包括天然生物材料、金屬生物材料、陶瓷生物材料和聚合生物材料。根據該報告，金屬生物材料代表了最大的細分市場。

此細分市場的成長是由於金屬生物材料所表現出的卓越強度、最佳耐用性和增強的生物相容性而推動的。因此，他們發現了廣泛的承重應用，包括牙科植入物、骨科植入物、心血管裝置等。其創新的UltraThineer材料。此外，不銹鋼、鈦、鈷鉻合金等多種金屬因其優異的機械性能而被廣泛使用，這些金屬性能可確保在身體運動壓力下的使用壽命和彈性。例如，2022 年 1 月，根據《Colloids and Surfaces A》雜誌報道，研究人員用奈米多孔 TiO2 有效修飾了 TC26 合金，以增強人工植入物的骨整合和生物活性。除此之外，2023年6月，莫斯科經濟特區科技城宣布生產鈦植入物。因此，不斷增加的產品應用將在未來幾年繼續推動金屬生物材料市場需求。

按應用分類：

神經病學

心臟病學

骨科

傷口護理

牙科

整型手術

其他

該報告根據應用程式提供了詳細的市場細分和分析。這包括神經病學、心臟病學、骨科、傷口護理、牙科、整形外科等。

耐用的陶瓷、金屬和聚合物材料對於關節置換和骨修復至關重要。此外，它們也被用於製造需要與口腔組織具有高相容性和強度的重建裝置。除此之外，包括神經病學和心臟病學在內的關鍵領域需要用於神經植入、腦機介面、支架、心律調節器等的生物材料。奎斯特生物醫學創新研究所的研究人員和加州大學洛杉磯分校開發了新型生物材料來促進新生血管並針對中風後免疫反應。根據生物材料市場統計數據，另一類包括藥物輸送系統和眼科等其他應用，其中生物材料分別為植入物和受管制藥物釋放提供量身定做的解決方案。

按地區分類：

北美洲

美國

加拿大

亞太

中國

日本

印度

韓國

澳洲

印尼

其他

歐洲

德國

法國

英國

義大利

西班牙

俄羅斯

其他

拉丁美洲

巴西

墨西哥

其他

中東和非洲

北美目前主導全球市場佔有率

市場研究報告還對所有主要區域市場進行了全面分析，其中包括北美（美國和加拿大）；亞太地區（中國、日本、印度、韓國、澳洲、印尼等）；歐洲（德國、法國、英國、義大利、西班牙、俄羅斯等）；拉丁美洲（巴西、墨西哥等）；以及中東和非洲。報告稱，北美佔據了最大的生物材料市場。

北美有利的監管環境，特別是美國食品和藥物管理局（FDA）的作用，支持新生物材料和醫療器材的快速批准和開發，正在推動該地區市場的發展。例如，2019 年 11 月，DiFusion Inc. 的 Xiphos-ZF 脊椎椎間裝置獲得 FDA 批准，該裝置基於不同的生物材料 Zfuze（鈦和聚醚醚酮的組合）。此外，2023年10月，生物材料平台公司之一Dimension Inx宣布FDA核准首款3D列印再生骨移植產品CMFlex。此外，越來越多的門診手術中心（ASC）進行脊椎手術是另一個重要的成長誘導因素。例如，2023 年 2 月，根據 Becker 的醫療保健資料顯示，美國有超過 183 個 ASC 進行微創脊椎手術 (MISS)。除此之外，整容手術的日益普及進一步刺激了區域市場。此外，包括美國國家科學基金會和美國國家標準與技術研究所在內的多個公共和私人組織發起的舉措，為生物材料的使用提供幫助，預計將在預測期內推動北美市場的發展。

本報告回答的關鍵問題

  • 2023年全球生物材料市場規模有多大？ 2024-2032年全球生物材料市場的預期成長率是多少？
  • 推動全球生物材料市場的關鍵因素是什麼？
  • COVID-19 對全球生物材料市場有何影響？
  • 全球生物材料市場按類型分類是怎樣的？
  • 全球生物材料市場的重點區域有哪些？
  • 誰是全球生物材料市場的主要參與者/公司？

目錄

第1章：前言

第 2 章：範圍與方法

  • 研究目的
  • 利害關係人
  • 數據來源
    • 主要來源
    • 二手資料
  • 市場預測
    • 自下而上的方法
    • 自上而下的方法
  • 預測方法

第 3 章：執行摘要

第 4 章：簡介

  • 概述
  • 主要行業趨勢

第 5 章：全球生物材料市場

  • 市場概況
  • 市場表現
  • COVID-19 的影響
  • 市場預測

第 6 章：市場區隔：按類型

  • 天然生物材料
    • 市場趨勢
    • 市場預測
  • 金屬生物材料
    • 市場趨勢
    • 市場預測
  • 陶瓷生物材料
    • 市場趨勢
    • 市場預測
  • 高分子生物材料
    • 市場趨勢
    • 市場預測

第 7 章：市場區隔：按應用

  • 神經病學
    • 市場趨勢
    • 市場預測
  • 心臟病學
    • 市場趨勢
    • 市場預測
  • 骨科
    • 市場趨勢
    • 市場預測
  • 傷口護理
    • 市場趨勢
    • 市場預測
  • 牙科
    • 市場趨勢
    • 市場預測
  • 整型手術
    • 市場趨勢
    • 市場預測
  • 其他
    • 市場趨勢
    • 市場預測

第 8 章：市場區隔：按地區

  • 北美洲
    • 美國
    • 加拿大
  • 亞太
    • 中國
    • 日本
    • 印度
    • 韓國
    • 澳洲
    • 印尼
    • 其他
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙
    • 俄羅斯
    • 其他
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他
  • 中東和非洲
    • 市場趨勢
    • 市場細分：按國家/地區
    • 市場預測

第 9 章：SWOT 分析

  • 概述
  • 優勢
  • 弱點
  • 機會
  • 威脅

第 10 章：價值鏈分析

第 11 章：波特五力分析

  • 概述
  • 買家的議價能力
  • 供應商的議價能力
  • 競爭程度
  • 新進入者的威脅
  • 替代品的威脅

第 12 章：價格分析

第13章：競爭格局

  • 市場結構
  • 關鍵參與者
  • 關鍵參與者簡介
    • BASF SE
    • Berkeley Advanced Biomaterials
    • Carpenter Technology Corporation
    • Collagen Matrix Inc.
    • CoorsTek Inc.
    • Corbion NV
    • Dentsply Sirona
    • Evonik Industries AG
    • Johnson & Johnson
    • Koninklijke DSM NV
    • Medtronic plc
    • Stryker Corporation
    • Victrex plc
    • Zimmer Biomet
Product Code: SR112024A5892

The global biomaterials market size reached US$ 114.6 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 276.6 Billion by 2032, exhibiting a growth rate (CAGR) of 10.1% during 2024-2032. Continuous advancements in the healthcare industry, along with the rising prevalence of cardiovascular diseases, are primarily propelling the market.

Biomaterials Market Analysis:

Major Market Drivers: The increasing number of individuals with musculoskeletal conditions represents one of the primary drivers stimulating the market. Additionally, the rising adoption of these materials in dissolvable sutures and dressings, staples, and clips for wound closure is also acting as another significant growth-inducing factor.

Key Market Trends: Several advancements in polymer synthesis, protein and peptide engineering, molecular self-assembly, and microfabrication technologies are among the emerging trends bolstering the market.

Geographical Trends: North America exhibits a clear dominance across the market, owing to the expanding geriatric population who often need medical interventions. Moreover, the inflating number of research institutions and robust healthcare infrastructures is impelling the growth of the regional market.

Competitive Landscape: As per the biomaterials market overview, some of the prominent companies include BASF SE, Berkeley Advanced Biomaterials, Carpenter Technology Corporation, Collagen Matrix Inc., CoorsTek Inc., Corbion N.V., Dentsply Sirona, Evonik Industries AG, Johnson & Johnson, Koninklijke DSM N.V., Medtronic plc, Stryker Corporation, Victrex plc, and Zimmer Biomet, among many others.

Challenges and Opportunities: Stringent regulatory frameworks and extensive preclinical testing are hampering the market. However, the introduction of more predictive in-vivo and in-vitro models to assess biocompatibility before clinical use is expected to augment the market over the forecasted period.

Biomaterials Market Trends:

Development of 3D Printing Technologies

The introduction of novel innovations, including 3D printing technologies, is improving the ways in which medical implants and devices are designed and manufactured. Moreover, they enable the production of patient-specific and complex shapes that are difficult or impossible to achieve with traditional methods. Consequently, these technologies find extensive applications in fields, such as dentistry, orthopedics, prosthetics, etc., where anatomical precision is crucial. This, in turn, is one of the lucrative biomaterials market recent opportunities. For example, in February 2024, Nanavati Max Super Specialty Hospital launched a medical 3D printing laboratory in Mumbai to facilitate high-precision surgeries. This pioneering facility is closely integrated with oncology to offer state-of-the-art precision surgeries that are required to be performed accurately and carefully in reconstructive orthopedic, oncologic, and specialized dentistry surgeries. Additionally, the widespread integration of 3D printing technology in biomaterials for creating customized and complex medical devices and implants tailored to individual patients' anatomies is further gaining extensive traction across the globe. For instance, in October 2023, a study was published that assisted the occupational therapists at the Haukeland University Hospital in Bergen to develop personalized hand orthoses by using 3D printing and scanning technologies, which can reduce pain, minimize deterioration, enhance patient compliance, etc. Apart from this, 3D printing allows for the incorporation of gradients of materials with varying mechanical properties, which is also positively influencing the market. For example, in October 2023, Evonik launched implant-grade filaments and carbon-fiber-reinforced PEEK for numerous medical applications. Furthermore, these technologies assist in the treatment of chronic diseases, which is projected to fuel the overall biomaterials market outlook in the coming years. For example, in July 2023, through joint research with the Korea Research Institute of Bioscience and Biotechnology, the Korea Institute of Machinery and Materials, and the institute under the jurisdiction of the Ministry of Science and ICT launched the world's first 3D bioprinting technology that enhances the function of natural killer (NK) immune cells.

Innovations in Tissue Engineering

Tissue engineering plays an important role in biomaterials research. It is gaining immense popularity for developing biological substitutes to maintain, restore, or improve tissue function. For example, in June 2023, OrganaBio announced the introduction of NeoPAC placenta and umbilical cord tissues that are specifically designed to accelerate the progress of regenerative medicine and cell therapy. Moreover, by providing both Research Use Only (RUO) and clinical-grade tissues, OrganaBio encourages researchers to tap into the potential of birth tissues, thereby enabling the development of innovative therapies to address numerous medical conditions. Apart from this, the rising demand for novel scaffolds that are materials engineered to cause desirable cellular interactions to facilitate the formation of new tissues is also elevating the market. For instance, in June 2023, 3DBioFibR, one of the leading innovators in tissue engineering, released two new collagen fiber products, namely CollaFibR 3D and μCollaFibR scaffold. These variants offer significant benefits for tissue culture and tissue engineering applications. Additionally, the elevating investments in R&D activities and research facilities by various organizations to enable the engineering of more structurally and functionally accurate tissues are contributing to the biomaterials market revenue. For example, in January 2023, the National Institute of Biomedical Imaging and Bioengineering (NIBIB) established the Center for Biomedical Engineering Technology Acceleration (BETA Center), a new intramural research program to accelerate the validation, development, and dissemination of cutting-edge technologies. The center focuses on several areas, such as biosensing, engineered and synthetic biology, biomedical imaging, nanomaterials and biomaterials, etc.

Growing Applications in Wound Dressings

The rising adoption of biomaterials in advanced wound dressings, as they help in improving the healing process and outcomes for numerous types of wounds, including acute and chronic injuries, is acting as a significant growth-inducing factor. Besides this, key players are developing sustainable materials for wound care. For example, in March 2024, a team of scientists at the Institute of Advanced Study in Science and Technology (IASST), under the Department of Science and Technology, introduced an eco-friendly wound dressing material made using banana fibers. Moreover, all the materials utilized in creating this innovative dressing material are locally available and natural, making the manufacturing process cost-effective, simple, and non-toxic. Apart from this, the increasing inclination towards bio-material-based wound dressings is elevating the biomaterials market prices. They can be produced from various materials, including foams, hydrogels, films, etc., that are often imbued with bioactive substances like antimicrobial agents to reduce infection and promote tissue regeneration. For instance, in May 2022, Amferia AB, a Swedish medical device startup, was granted a foundational patent by the U.S. Patent and Trademark Office (USPTO) for an antimicrobial material based on an amphiphilic antimicrobial hydrogel. In line with this, in June 2023, according to the findings published in the Journal of Biomaterials Advances, a team of researchers from Queen's University of Belfast designed a 3D printed bandage, also called a scaffold, which presents an innovative method of treatment to heal diabetic foot ulcers (DFUs).

Global Biomaterials Market Segmentation:

IMARC Group provides an analysis of the key trends in each segment of the market, along with the biomaterials market forecast at the global, regional, and country levels for 2024-2032. Our report has categorized the market based on the type and application.

Breakup by Type:

Natural Biomaterial

Metallic Biomaterial

Ceramic Biomaterial

Polymeric Biomaterial

Currently, metallic biomaterial accounts for the largest market share

The report has provided a detailed breakup and analysis of the market based on the type. This includes natural biomaterial, metallic biomaterial, ceramic biomaterial, and polymeric biomaterial. According to the report, metallic biomaterial represented the largest segmentation.

The growth in this segmentation is driven due to exceptional strength, optimal durability, and enhanced biocompatibility exhibited by metallic biomaterials. Consequently, they find extensive load-bearing applications, including dental implants, orthopedic implants, cardiovascular devices, etc. For instance, in April 2024, Boston Micro Fabrication (BMF) announced the U.S. Food and Drug Administration (FDA) clearance for its innovative UltraThineer material. Moreover, several metals, such as stainless steel, titanium, cobalt-chromium alloys, etc., are widely used, owing to their superior mechanical properties that ensure longevity and resilience under the stress of bodily movements. For example, in January 2022, according to the journal Colloids and Surfaces A, researchers efficiently modified a TC26 alloy with nanoporous TiO2 to enhance the osseointegration and bioactivity of artificial implants. In addition to this, in June 2023, Technopolis Moscow SEZ announced the production of titanium implants. As a result, the increasing product applications will continue to drive the metallic biomaterials market demand in the coming years.

Breakup by Application:

Neurology

Cardiology

Orthopedics

Wound Care

Dental

Plastic Surgery

Others

The report has provided a detailed breakup and analysis of the market based on the application. This includes neurology, cardiology, orthopedics, wound care, dental, plastic surgery, and others.

Durable ceramic, metallic, and polymer-based materials are essential for joint replacements and bone repair. Moreover, they are adopted in the manufacturing of reconstructive devices that require high compatibility and strength with oral tissues. Apart from this, key areas, including neurology and cardiology, require biomaterials for neural implants, brain-machine interfaces, stents, pacemakers, etc. For instance, in February 2022, Researchers at the Lundquist Institute for Biomedical Innovation, Penn State, and the University of California Los Angeles developed novel biomaterials to promote new blood vessels and target post-stroke immune responses. According to the biomaterials market statistics, the other category encompasses additional applications like drug delivery systems and ophthalmology, where biomaterials offer tailored solutions for implants and controlled medication release, respectively.

Breakup by Region:

North America

United States

Canada

Asia-Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

North America currently dominates the global market share

The market research report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America accounted for the largest biomaterials market share.

The favorable regulatory environment in North America, particularly the role of the U.S. Food and Drug Administration (FDA), which supports the rapid approval and development of new biomaterials and medical devices, is fueling the regional market. For example, in November 2019, DiFusion Inc. received FDA approval for its Xiphos-ZF spinal interbody device, which is based on a different biomaterial Zfuze, a combination of titanium and poly-ether-ether-ketone. Additionally, in October 2023, Dimension Inx, one of the biomaterials platform companies, announced the FDA approval of CMFlex, the first 3D-printed regenerative bone graft product. Moreover, the growing number of ambulatory surgical centers (ASCs) that perform spinal surgeries is acting as another significant growth-inducing factor. For instance, in February 2023, according to Becker's Healthcare data showcased that more than 183 ASCs in the United States perform minimally invasive spine surgery (MISS). Apart from this, the inflating popularity of cosmetic surgeries is further stimulating the regional market. In addition, the launch of initiatives undertaken by several public and private organizations, including the National Science Foundation and the National Institute of Standards and Technology, which provide assistance pertaining to biomaterials usage, is expected to fuel the market in North America over the forecasted period.

Competitive Landscape:

The market research report has provided a comprehensive analysis of the competitive landscape. Detailed profiles of all major biomaterials market companies have also been provided. Some of the key players in the market include:

BASF SE

Berkeley Advanced Biomaterials

Carpenter Technology Corporation

Collagen Matrix Inc.

CoorsTek Inc.

Corbion N.V.

Dentsply Sirona

Evonik Industries AG

Johnson & Johnson

Koninklijke DSM N.V.

Medtronic plc

Stryker Corporation

Victrex plc

Zimmer Biomet

(Please note that this is only a partial list of the key players, and the complete list is provided in the report.)

Biomaterials Market Recent Developments:

February 2024: 3D Systems, one of the U.S.-based 3D printer manufacturers, launched its new multi-material 3D printed denture offering.

February 2024: Researchers from MIT introduced a 3D-printable tissue adhesive that demonstrates superior tissue adhesion. This technology holds immense potential for enhancing biomedical devices and wound care applications.

January 2024: Evonik introduced the world's first carbon-fiber-reinforced PEEK filament for long-term 3D-printed medical implants.

January 2024: restor3d, one of the musculoskeletal implant specialists, successfully commercialized femoral implants produced via a previously cleared additive manufacturing method, outperforming the mechanical properties of cast implants.

Key Questions Answered in This Report

  • 1. What was the size of the global biomaterials market in 2023?
  • 2. What is the expected growth rate of the global biomaterials market during 2024-2032?
  • 3. What are the key factors driving the global biomaterials market?
  • 4. What has been the impact of COVID-19 on the global biomaterials market?
  • 5. What is the breakup of the global biomaterials market based on type?
  • 6. What are the key regions in the global biomaterials market?
  • 7. Who are the key players/companies in the global biomaterials market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Biomaterials Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Type

  • 6.1 Natural Biomaterial
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Metallic Biomaterial
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Ceramic Biomaterial
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast
  • 6.4 Polymeric Biomaterial
    • 6.4.1 Market Trends
    • 6.4.2 Market Forecast

7 Market Breakup by Application

  • 7.1 Neurology
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Cardiology
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Orthopedics
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Wound Care
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast
  • 7.5 Dental
    • 7.5.1 Market Trends
    • 7.5.2 Market Forecast
  • 7.6 Plastic Surgery
    • 7.6.1 Market Trends
    • 7.6.2 Market Forecast
  • 7.7 Others
    • 7.7.1 Market Trends
    • 7.7.2 Market Forecast

8 Market Breakup by Region

  • 8.1 North America
    • 8.1.1 United States
      • 8.1.1.1 Market Trends
      • 8.1.1.2 Market Forecast
    • 8.1.2 Canada
      • 8.1.2.1 Market Trends
      • 8.1.2.2 Market Forecast
  • 8.2 Asia-Pacific
    • 8.2.1 China
      • 8.2.1.1 Market Trends
      • 8.2.1.2 Market Forecast
    • 8.2.2 Japan
      • 8.2.2.1 Market Trends
      • 8.2.2.2 Market Forecast
    • 8.2.3 India
      • 8.2.3.1 Market Trends
      • 8.2.3.2 Market Forecast
    • 8.2.4 South Korea
      • 8.2.4.1 Market Trends
      • 8.2.4.2 Market Forecast
    • 8.2.5 Australia
      • 8.2.5.1 Market Trends
      • 8.2.5.2 Market Forecast
    • 8.2.6 Indonesia
      • 8.2.6.1 Market Trends
      • 8.2.6.2 Market Forecast
    • 8.2.7 Others
      • 8.2.7.1 Market Trends
      • 8.2.7.2 Market Forecast
  • 8.3 Europe
    • 8.3.1 Germany
      • 8.3.1.1 Market Trends
      • 8.3.1.2 Market Forecast
    • 8.3.2 France
      • 8.3.2.1 Market Trends
      • 8.3.2.2 Market Forecast
    • 8.3.3 United Kingdom
      • 8.3.3.1 Market Trends
      • 8.3.3.2 Market Forecast
    • 8.3.4 Italy
      • 8.3.4.1 Market Trends
      • 8.3.4.2 Market Forecast
    • 8.3.5 Spain
      • 8.3.5.1 Market Trends
      • 8.3.5.2 Market Forecast
    • 8.3.6 Russia
      • 8.3.6.1 Market Trends
      • 8.3.6.2 Market Forecast
    • 8.3.7 Others
      • 8.3.7.1 Market Trends
      • 8.3.7.2 Market Forecast
  • 8.4 Latin America
    • 8.4.1 Brazil
      • 8.4.1.1 Market Trends
      • 8.4.1.2 Market Forecast
    • 8.4.2 Mexico
      • 8.4.2.1 Market Trends
      • 8.4.2.2 Market Forecast
    • 8.4.3 Others
      • 8.4.3.1 Market Trends
      • 8.4.3.2 Market Forecast
  • 8.5 Middle East and Africa
    • 8.5.1 Market Trends
    • 8.5.2 Market Breakup by Country
    • 8.5.3 Market Forecast

9 SWOT Analysis

  • 9.1 Overview
  • 9.2 Strengths
  • 9.3 Weaknesses
  • 9.4 Opportunities
  • 9.5 Threats

10 Value Chain Analysis

11 Porters Five Forces Analysis

  • 11.1 Overview
  • 11.2 Bargaining Power of Buyers
  • 11.3 Bargaining Power of Suppliers
  • 11.4 Degree of Competition
  • 11.5 Threat of New Entrants
  • 11.6 Threat of Substitutes

12 Price Analysis

13 Competitive Landscape

  • 13.1 Market Structure
  • 13.2 Key Players
  • 13.3 Profiles of Key Players
    • 13.3.1 BASF SE
      • 13.3.1.1 Company Overview
      • 13.3.1.2 Product Portfolio
      • 13.3.1.3 Financials
      • 13.3.1.4 SWOT Analysis
    • 13.3.2 Berkeley Advanced Biomaterials
      • 13.3.2.1 Company Overview
      • 13.3.2.2 Product Portfolio
    • 13.3.3 Carpenter Technology Corporation
      • 13.3.3.1 Company Overview
      • 13.3.3.2 Product Portfolio
      • 13.3.3.3 Financials
      • 13.3.3.4 SWOT Analysis
    • 13.3.4 Collagen Matrix Inc.
      • 13.3.4.1 Company Overview
      • 13.3.4.2 Product Portfolio
    • 13.3.5 CoorsTek Inc.
      • 13.3.5.1 Company Overview
      • 13.3.5.2 Product Portfolio
    • 13.3.6 Corbion N.V.
      • 13.3.6.1 Company Overview
      • 13.3.6.2 Product Portfolio
      • 13.3.6.3 Financials
    • 13.3.7 Dentsply Sirona
      • 13.3.7.1 Company Overview
      • 13.3.7.2 Product Portfolio
      • 13.3.7.3 Financials
      • 13.3.7.4 SWOT Analysis
    • 13.3.8 Evonik Industries AG
      • 13.3.8.1 Company Overview
      • 13.3.8.2 Product Portfolio
      • 13.3.8.3 Financials
      • 13.3.8.4 SWOT Analysis
    • 13.3.9 Johnson & Johnson
      • 13.3.9.1 Company Overview
      • 13.3.9.2 Product Portfolio
      • 13.3.9.3 Financials
      • 13.3.9.4 SWOT Analysis
    • 13.3.10 Koninklijke DSM N.V.
      • 13.3.10.1 Company Overview
      • 13.3.10.2 Product Portfolio
      • 13.3.10.3 Financials
      • 13.3.10.4 SWOT Analysis
    • 13.3.11 Medtronic plc
      • 13.3.11.1 Company Overview
      • 13.3.11.2 Product Portfolio
      • 13.3.11.3 Financials
      • 13.3.11.4 SWOT Analysis
    • 13.3.12 Stryker Corporation
      • 13.3.12.1 Company Overview
      • 13.3.12.2 Product Portfolio
      • 13.3.12.3 Financials
      • 13.3.12.4 SWOT Analysis
    • 13.3.13 Victrex plc
      • 13.3.13.1 Company Overview
      • 13.3.13.2 Product Portfolio
      • 13.3.13.3 Financials
    • 13.3.14 Zimmer Biomet
      • 13.3.14.1 Company Overview
      • 13.3.14.2 Product Portfolio
      • 13.3.14.3 Financials
      • 13.3.14.4 SWOT Analysis

List of Figures

  • Figure 1: Global: Biomaterials Market: Major Drivers and Challenges
  • Figure 2: Global: Biomaterials Market: Sales Value (in Billion US$), 2018-2023
  • Figure 3: Global: Biomaterials Market Forecast: Sales Value (in Billion US$), 2024-2032
  • Figure 4: Global: Biomaterials Market: Breakup by Type (in %), 2023
  • Figure 5: Global: Biomaterials Market: Breakup by Application (in %), 2023
  • Figure 6: Global: Biomaterials Market: Breakup by Region (in %), 2023
  • Figure 7: Global: Biomaterials (Natural Biomaterial) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 8: Global: Biomaterials (Natural Biomaterial) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 9: Global: Biomaterials (Metallic Biomaterial) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 10: Global: Biomaterials (Metallic Biomaterial) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 11: Global: Biomaterials (Ceramic Biomaterial) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 12: Global: Biomaterials (Ceramic Biomaterial) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 13: Global: Biomaterials (Polymeric Biomaterial) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 14: Global: Biomaterials (Polymeric Biomaterial) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 15: Global: Biomaterials (Neurology) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 16: Global: Biomaterials (Neurology) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 17: Global: Biomaterials (Cardiology) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 18: Global: Biomaterials (Cardiology) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 19: Global: Biomaterials (Orthopedics) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 20: Global: Biomaterials (Orthopedics) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 21: Global: Biomaterials (Wound Care) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 22: Global: Biomaterials (Wound Care) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 23: Global: Biomaterials (Dental) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 24: Global: Biomaterials (Dental) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 25: Global: Biomaterials (Plastic Surgery) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 26: Global: Biomaterials (Plastic Surgery) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 27: Global: Biomaterials (Other Applications) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 28: Global: Biomaterials (Other Applications) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 29: North America: Biomaterials Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 30: North America: Biomaterials Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 31: United States: Biomaterials Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 32: United States: Biomaterials Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 33: Canada: Biomaterials Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 34: Canada: Biomaterials Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 35: Asia-Pacific: Biomaterials Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 36: Asia-Pacific: Biomaterials Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 37: China: Biomaterials Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 38: China: Biomaterials Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 39: Japan: Biomaterials Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 40: Japan: Biomaterials Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 41: India: Biomaterials Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 42: India: Biomaterials Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 43: South Korea: Biomaterials Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 44: South Korea: Biomaterials Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 45: Australia: Biomaterials Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 46: Australia: Biomaterials Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 47: Indonesia: Biomaterials Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 48: Indonesia: Biomaterials Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 49: Others: Biomaterials Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 50: Others: Biomaterials Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 51: Europe: Biomaterials Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 52: Europe: Biomaterials Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 53: Germany: Biomaterials Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 54: Germany: Biomaterials Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 55: France: Biomaterials Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 56: France: Biomaterials Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 57: United Kingdom: Biomaterials Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 58: United Kingdom: Biomaterials Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 59: Italy: Biomaterials Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 60: Italy: Biomaterials Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 61: Spain: Biomaterials Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 62: Spain: Biomaterials Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 63: Russia: Biomaterials Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 64: Russia: Biomaterials Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 65: Others: Biomaterials Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 66: Others: Biomaterials Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 67: Latin America: Biomaterials Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 68: Latin America: Biomaterials Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 69: Brazil: Biomaterials Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 70: Brazil: Biomaterials Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 71: Mexico: Biomaterials Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 72: Mexico: Biomaterials Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 73: Others: Biomaterials Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 74: Others: Biomaterials Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 75: Middle East and Africa: Biomaterials Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 76: Middle East and Africa: Biomaterials Market: Breakup by Country (in %), 2023
  • Figure 77: Middle East and Africa: Biomaterials Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 78: Global: Biomaterials Industry: SWOT Analysis
  • Figure 79: Global: Biomaterials Industry: Value Chain Analysis
  • Figure 80: Global: Biomaterials Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Biomaterials Market: Key Industry Highlights, 2023 and 2032
  • Table 2: Global: Biomaterials Market Forecast: Breakup by Type (in Million US$), 2024-2032
  • Table 3: Global: Biomaterials Market Forecast: Breakup by Application (in Million US$), 2024-2032
  • Table 4: Global: Biomaterials Market Forecast: Breakup by Region (in Million US$), 2024-2032
  • Table 5: Global: Biomaterials Market: Competitive Structure
  • Table 6: Global: Biomaterials Market: Key Players